Abstract
The aim of this study is to determine the efficacy of exoantigens derived from Babesia gibsoni cultures to induce protective immunity against challenge exposure of virulent organisms. An attenuated B. gibsoni Oita strain was maintained in vitro by the microaerophilus stationary phase (MASP) method, and exoantigens-containing supernatant fluids were collected for preparation of the immunization. Two dogs received three subcutaneous immunizations with a 20-day interval of B. gibsoni exoantigens plus 0.5 mg saponin (Quil A). On day 68 after the prime immunization, the immunized dogs and control dogs were challenged intravenously with 2 × 108 virulent parasites of a homologous B. gibsoni strain. The results showed that exoantigens could induce a high degree of protection against virulent homologous challenge exposure. Two dogs immunized with exoantigens showed a lower parasitemia, accompanied by a slight decrease in the PCV that returned to normal values. Control dogs developed typical acute clinical signs, including severe anemia and hyperthermia. The immunization elicited humoral immune responses. In dogs immunized with exoantigens, the maximum antibody titer was 2,560 and 5,120 by indirect fluorescent antibody test (IFAT), respectively. Preliminary Western blot analysis of the immunogen revealed five dominant proteins of molecular weights of 18, 37, 43, 50, and 57 kDa. These results suggested that the culture-derived exoantigens were candidates for non-viable vaccine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Birkenheuer AJ, Levy MG, Breitschwerdt EB (2004) Efficacy of combined atovaquone and azithromycin for therapy of chronic Babesia gibsoni (Asian genotype) infections in dogs. J Vet Intern Med 18(4):494–498
Boozer AL, Macintire DK (2003) Canine babesiosis. Vet Clin N Am Small Anim Pract 33(4):885–904, viii
Farwell GE, LeGrand EK, Cobb CC (1982) Clinical observations on Babesia gibsoni and Babesia canis infections in dogs. J Am Vet Med Assoc 180(5):507–511
Fish L, Leibovich B, Krigel Y, McElwain T, Shkap V (2008) Vaccination of cattle against B. bovis infection with live attenuated parasites and non-viable immunogens. Vaccine 26 Suppl 6:G29–33
Fukumoto S et al (2001) Identification and expression of a 50-kilodalton surface antigen of Babesia gibsoni and evaluation of its diagnostic potential in an enzyme-linked immunosorbent assay. J Clin Microbiol 39(7):2603–2609
Fukumoto S, Tamaki Y, Shirafuji H, Harakawa S, Suzuki H, Xuan X (2005) Immunization with recombinant surface antigen P50 of Babesia gibsoni expressed in insect cells induced parasite growth inhibition in dogs. Clin Diagn Lab Immunol 12(4):557–559
Fukumoto S et al (2007) Prime-boost immunization with DNA followed by a recombinant vaccinia virus expressing P50 induced protective immunity against Babesia gibsoni infection in dogs. Vaccine 25(7):1334–1341
Fukumoto S, Tamaki Y, Igarashi I, Suzuki H, Xuan X (2009) Immunogenicity and growth inhibitory efficacy of the prime-boost immunization regime with DNA followed by recombinant vaccinia virus carrying the P29 gene of Babesia gibsoni in dogs. Exp Parasitol 123(4):296–301
Grande N, Precigout E, Camillieri S, Carcy B, Moubri K, Gorenflot A (1998) Comparison between aseric and seric culture-derived exoantigens of Babesia divergens in their ability to induce immunoprotection in gerbils. Parasitol Int 47(4):269–279
Jefferies R, Ryan UM, Jardine J, Robertson ID, Irwin PJ (2007) Babesia gibsoni: detection during experimental infections and after combined atovaquone and azithromycin therapy. Exp Parasitol 117(2):115–123
Levy MG, Ristic M (1980) Babesia bovis: continuous cultivation in a microaerophilous stationary phase culture. Science 207(4436):1218–1220
Mishell BB, Shiigi SM (1980) Selected methods in cellular immunology. WH Freeman, San Francisco, p 23
Montenegro-James S, Ristic M, Toro Benitez M, Leon E, Lopez R (1985) Heterologous strain immunity in bovine babesiosis using a culture-derived soluble Babesia bovis immunogen. Vet Parasitol 18(4):321–337
Montenegro-James S, Toro Benitez M, Leon E, Lopez R, Ristic M (1987) Bovine babesiosis: induction of protective immunity with culture-derived Babesia bovis and Babesia bigemina immunogens. Parasitol Res 74(2):142–150
Moreau Y, Laurent N (1984) Antibabesial vaccination using antigens from cell culture fluids: Malaria and Babesiosis. New Perspectives in Clinical Microbiology, vol 7. Springer, Netherlands, p 129–140
Patarroyo JH, Prates AA, Tavares CA, Mafra CL, Vargas MI (1995) Exoantigens of an attenuated strain of Babesia bovis used as a vaccine against bovine babesiosis. Vet Parasitol 59(3–4):189–199
Sakuma M, Setoguchi A, Endo Y (2009) Possible emergence of drug-resistant variants of Babesia gibsoni in clinical cases treated with atovaquone and azithromycin. J Vet Intern Med 23(3):493–498
Schetters T (2005) Vaccination against canine babesiosis. Trends Parasitol 21(4):179–184
Schetters TP, Montenegro-James S (1995) Vaccines against babesiosis using soluble parasite antigens. Parasitol Today 11(12):456–462
Schetters TP, Kleuskens JA, Scholtes NC, Pasman JW, Bos HJ (1994) Vaccination of dogs against Babesia canis infection using antigens from culture supernatants with emphasis on clinical babesiosis. Vet Parasitol 52(3–4):219–233
Schetters TH, Kleuskens J, Scholtes N, Bos HJ (1995) Strain variation limits protective activity of vaccines based on soluble Babesia canis antigens. Parasite Immunol 17(4):215–218
Schetters TP, Scholtes NC, Kleuskens JA, Bos HJ (1996) Not peripheral parasitaemia but the level of soluble parasite antigen in plasma correlates with vaccine efficacy against Babesia canis. Parasite Immunol 18(1):1–6
Shkap V, de Vos AJ, Zweygarth E, Jongejan F (2007) Attenuated vaccines for tropical theileriosis, babesiosis and heartwater: the continuing necessity. Trends Parasitol 23(9):420–426
Simard CL, Briscoe MR (1990) An enzyme-linked immunosorbent assay for detection of antibodies to maedi-visna virus in sheep. I. A simple technique for production of antigen using sodium dodecyl sulfate treatment. Can J Vet Res 54(4):446–450
Sunaga F, Namikawa K, Kanno Y (2002a) Continuous in vitro culture of erythrocytic stages of Babesia gibsoni and virulence of the cultivated parasite. J Vet Med Sci 64(7):571–575
Sunaga F, Namikawa K, Kanno Y (2002b) Protection of dogs against homologous challenge by the inoculation of irradiated Babesia gibsoni. J Anim Protozooses 17(1):15–18
Sunaga F, Taharaguchi S, Arai S, Itoh S, Kanno Y (2013) Virulence attenuation of Babesia gibsoni by serial passages in vitro and assessment of the protection provided by the immunization against the passaged isolate in dogs. Vet Parasitol 197(3–4):565–570
Timms P, Dalgliesh RJ, Barry DN, Dimmock CK, Rodwell BJ (1983) Babesia bovis: comparison of culture-derived parasites, non-living antigen and conventional vaccine in the protection of cattle against heterologous challenge. Aust Vet J 60(3):75–77
Zhao JL, Liu ZL, Yao BA, Ma LH (2002) Culture-derived Babesia orientalis exoantigens used as a vaccine against buffalo babesiosis. Parasitol Res 88(13 Suppl 1):S38–S40
Acknowledgments
We thank Y. Masamichi, S. Kashihara, S. Kokubo, and R. Hayase for the technical assistance and Y. Sunaga for helpful discussions and critical review of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sunaga, F., Arai, S., Itoh, S. et al. Protective efficacy of Babesia gibsoni culture-derived exoantigens against the challenge infection in dogs. Parasitol Res 113, 1681–1686 (2014). https://doi.org/10.1007/s00436-014-3812-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-014-3812-1